Lead sponsor

University of Western Sydney

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

1

Active

15

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Not applicable
1

Trials by status

Recruiting
1

Trials led

Body Surface Gastric Mapping in Patients on SemaglutideHbA1c ≥7%not applicableRecruiting15